Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt, 
consult the original text.
The Butantan Institute develops an original research of a new drug to relieve pain resulting from nerve injuries and inflammation. The first results of the study, applied to animals, and were evaluated by researchers.
The new platform, developed by researchers at the Laboratory of Pathophysiology aims to understand the workings of a protein found in blood, specifically the white blood cells, called S100A9 calcium binding.
Initial tests with this showed that the drug substance has a good action even at low dose and easy oral administration, which would make possible the production costs. Besides these properties, the action of the protein also proved effective in the treatment of acute and chronic injuries.
The initial results were encouraging and our expectation is to enable an improvement in the treatment of some diseases and quality of life, says Renata Giorgi, scientific researcher of the Laboratory of Pathophysiology of Butantan Institute.
The next step is to evaluate the toxicity of the substance and conduct the first tests in humans.
Share this page
Correct
Share
Alert
Palavras-chave: 
